Holdings of NEXTBio Capital Management LP
· Original filing · Compare with another fund · Report an error
- Net assets
- -
- Positions
- 21 in 4 countries
- Top ten
- 77.0 % of the equity sleeve
- Filed on
- Mar 31, 2026
Portfolio shape
Positions
| Rank | Company | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | Terns Pharmaceuticals Inc | 604,534 | 31.9M $ | |
| 2 | Protagonist Therapeutics Inc | 229,619 | 24.2M $ | |
| 3 | Shattuck Labs Inc | 3,149,907 | 20.3M $ | |
| 4 | VOR BIOPHARMA INC | 999,967 | 17.8M $ | |
| 5 | COMPASS PATHWAYS PLC | 2,021,407 | 11.2M $ | |
| 6 | Rhythm Pharmaceuticals Inc | 126,078 | 11M $ | |
| 7 | PALVELLA THERAPEUTICS INC | 82,686 | 10.3M $ | |
| 8 | ZENAS BIOPHARMA INC | 426,736 | 8.3M $ | |
| 9 | INVENTIVA SA | 1,333,484 | 7.4M $ | |
| 10 | VERASTEM INC | 1,306,800 | 6.9M $ | |
| 11 | ORIC Pharmaceuticals Inc | 523,619 | 6.6M $ | |
| 12 | STRUCTURE THERAPEUTICS INC | 133,239 | 6.4M $ | |
| 13 | VAXCYTE INC | 95,223 | 5.5M $ | |
| 14 | COGENT BIOSCIENCES INC | 131,188 | 5M $ | |
| 15 | Compass Therapeutics Inc | 848,204 | 4.5M $ | |
| 16 | Evommune Inc | 184,063 | 4.2M $ | |
| 17 | ZAI LAB LTD | 183,362 | 3.4M $ | |
| 18 | Disc Medicine Inc | 52,655 | 3.4M $ | |
| 19 | KalVista Pharmaceuticals Inc | 131,796 | 2.7M $ | |
| 20 | Summit Therapeutics Inc | 89,717 | 1.7M $ | |
| 21 | Adicet Bio Inc | 157,827 | 1.1M $ |
Sector breakdown
- Unattributed 100.0 %
Titelia assigns each company to a sector, one by one. The unassigned share stays visible, under "Unattributed".
Currency breakdown
- USD 100.0 %
Each line is counted in its quoted currency, as the fund declares it.
Country breakdown
- United States 88.6 %
- United Kingdom 5.8 %
- France 3.8 %
- Cayman Islands 1.8 %
Shares are computed on the fund's equities only.
| Rank | Country | Lines | Value | Share |
|---|---|---|---|---|
| 1 | United States | 18 | 171.9M $ | 88.64 % |
| 2 | United Kingdom | 1 | 11.2M $ | 5.77 % |
| 3 | France | 1 | 7.4M $ | 3.82 % |
| 4 | Cayman Islands | 1 | 3.4M $ | 1.78 % |
Cite this page
Titelia. "Holdings of NEXTBio Capital Management LP". https://titelia.com/en/funds/US13F2038158